Treatable

Hepatitis B surface antigen vaccine

Inactivated Hepatitis B Virus Vaccine

Hepatitis B surface antigen vaccine Prefilled Syringe

DosageBrandImage
0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled SyringeGeneric
0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis]Generic
0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled SyringeGeneric
0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX]Generic
0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled SyringeGeneric
0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]Generic
0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled SyringeGeneric
0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B]Generic
0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled SyringeGeneric
0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B]Generic
1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled SyringeGeneric
1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Twinrix]Generic
1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled SyringeGeneric
1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]Generic
1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled SyringeGeneric
1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B]Generic

Hepatitis B surface antigen vaccine Injection

DosageBrandImage
0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML InjectionGeneric
0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Vaxelis]Generic
0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML InjectionGeneric
0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injection [Recombivax]Generic
0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML InjectionGeneric
0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML InjectionGeneric
0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Heplisav-B]Generic
1 ML hepatitis B surface antigen vaccine 0.01 MG/ML InjectionGeneric
1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injection [Recombivax]Generic
1 ML hepatitis B surface antigen vaccine 0.02 MG/ML InjectionGeneric
1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injection [Engerix-B]Generic
1 ML hepatitis B surface antigen vaccine 0.04 MG/ML InjectionGeneric
1 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Recombivax]Generic

Hepatitis B surface antigen vaccine may prevent:

Hepatitis B surface antigen vaccine contraindicated conditions:

Hepatitis B surface antigen vaccine desired effects:

  • Increased Antibody Activity
  • Increased Antibody Production
  • Actively Acquired Immunity

Hepatitis B surface antigen vaccine drug classes:

  • Inactivated Hepatitis B Virus Vaccine

Hepatitis B surface antigen vaccine mechanism of action:

  • Immunologic Factor Interactions
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2021
Last updated: 1/20/2022, 9:27:19 AM